Larimar Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Larimar Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2014 to Q1 2024.
  • Larimar Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $80K, a 2.56% increase year-over-year.
  • Larimar Therapeutics, Inc. annual Depreciation for 2023 was $311K, a 2.2% decline from 2022.
  • Larimar Therapeutics, Inc. annual Depreciation for 2022 was $318K, a 2.45% decline from 2021.
  • Larimar Therapeutics, Inc. annual Depreciation for 2021 was $326K, a 110% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $80K +$2K +2.56% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $78K -$4K -4.88% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $82K +$9K +12.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $100K Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-12
Q1 2021 $73K +$50K +217% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $23K -$28K -54.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $51K +$1K +2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $50K +$9K +22% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $41K -$9K -18% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-09
Q1 2016 $50K +$45K +900% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q1 2015 $5K +$2K +66.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q1 2014 $3K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.